 |
|
imexon
A 2-cyanoaziridine derivative with antitumor activity in multiple myeloma. Although its mechanism of action is not clearly known, imexon may induce apoptosis via a pathway involving cleaved caspase-3, caspase-9, and/or caspase-8. Other cytotoxic mechanisms of action of this agent may involve thiol depletion, generation of reactive oxygen species (ROS), and decreases in the mitochondrial membrane potential. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Amplimexon | | | | Chemical structure name: | | 4-imino-1,3-diazabicyclo[3,1,0]-hexan-2-one | | |
| Previous: | IL-2/Lptn gene-modified allogeneic neuroblastoma tumor cell vaccine, iloprost, Ilotycin, Imagent, imatinib mesylate | | Next: | imidazole mustard, imipenem, imiquimod, ImmTher, Immucell WGP |
|
|
